News & Events

CTI Partners with Humanigen for Planned Phase II Study for Lenzilumab for Coronavirus Treatment

March 30, 2020

Study to tackle leading cause of death in COVID-19 patients Lenzilumab, a monoclonal antibody that neutralizes granulocyte macrophage colony stimulating factor (GM-CSF) GM-CSF is up-regulated in COVID-19 patients and may cause a harmful immune response leading to ...

Read More

How CTI Can Help Fight the Impact of COVID-19

March 27, 2020

What CTI Can Do to Help Fight the Impact of COVID-19 CTI is dedicated to helping our partners, team members, and communities work through the COVID-10 pandemic. Whether that means helping adjust programs impacted ...

Read More

New Hires & Promotions

March 26, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Tolu Agbede promoted to Clinical Research Associate I Christiane Bradaczek joins as Senior Clinical Research Associate Dario Corrari joins as Senior Clinical Research Associate Nick DelBuono joins ...

Read More

CTI Announces Promotions in the Training and Information Technology Departments

March 12, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ March 12, 2020] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization (CRO) ...

Read More

CTI Medical Director to Lead Tri-State American Society of Hematology Update

March 6, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ March 6, 2020] Dr. Elias Anaissie, Medical Director at CTI Clinical Trial and Consulting (CTI), a global, privately held, full-service contract research organization, will be directing the Tri-State American Society of Hematology (ASH) Update on Saturday, March 7 in Cincinnati, OH. The annual ...

Read More

Subscribe to our mailing list

* indicates required
What best describes your relationship with CTI?
Areas of Interest (check all that apply)

Please select all the ways you would like to hear from CTI Clinical Trial & Consulting:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

View Privacy Policy